GoHealth Financials
GOCO Stock | USD 19.15 1.13 6.27% |
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Current Ratio | 1.38 | 1.16 |
|
|
The financial analysis of GoHealth is a critical element in measuring its lifeblood. Investors should not minimize GoHealth's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
Net Income |
|
GoHealth | Select Account or Indicator |
Understanding current and past GoHealth Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of GoHealth's financial statements are interrelated, with each one affecting the others. For example, an increase in GoHealth's assets may result in an increase in income on the income statement.
GoHealth Stock Summary
GoHealth competes with EHealth, Tian Ruixiang, Huize Holding, Selectquote, and CorVel Corp. GoHealth, Inc. operates as a health insurance marketplace and Medicare focused digital health company in the United States. GoHealth, Inc. was founded in 2001 and is headquartered in Chicago, Illinois with additional offices in Charlotte, North Carolina, Lindon, Utah, Bratislava, Slovakia, and Kosice, Slovakia. Gohealth Inc operates under Insurance Brokers classification in the United States and is traded on NASDAQ Exchange. It employs 5448 people.Specialization | Financial Services, Insurance Brokers |
Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
ISIN | US38046W1053 |
CUSIP | 38046W105 38046W204 |
Location | Illinois; U.S.A |
Business Address | 222 West Merchandise |
Sector | Insurance |
Industry | Financials |
Benchmark | Dow Jones Industrial |
Website | www.gohealth.com |
Phone | 312 386 8200 |
Currency | USD - US Dollar |
GoHealth Key Financial Ratios
Return On Equity | -0.16 | ||||
Profit Margin | (0.04) % | ||||
Operating Margin | (0.35) % | ||||
Price To Sales | 0.64 X | ||||
Revenue | 734.67 M |
GoHealth Key Balance Sheet Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Total Assets | 2.1B | 2.1B | 1.7B | 1.5B | 1.7B | 1.7B | |
Other Current Liab | 35.3M | 55.0M | 54.5M | 100.4M | 115.4M | 121.2M | |
Other Liab | 340.9M | 185.8M | 274.4M | 259.0M | 233.1M | 214.6M | |
Net Tangible Assets | (309.2M) | (694.9M) | (241.6M) | (182.6M) | (209.9M) | (220.4M) | |
Net Debt | 256.3M | 611.9M | 541.0M | 452.2M | 520.1M | 393.3M | |
Retained Earnings | (18.8M) | (208.3M) | (357.0M) | (420.3M) | (378.3M) | (397.2M) | |
Accounts Payable | 87.2M | 144.0M | 137.2M | 136.4M | 156.9M | 110.6M | |
Cash | 144.2M | 84.4M | 16.5M | 90.8M | 104.4M | 63.9M | |
Other Assets | 282.9M | 624.3M | 997.5M | 697.4M | 802.0M | 589.4M | |
Net Receivables | 205.7M | 285.9M | 340.5M | 336.5M | 386.9M | 246.2M | |
Long Term Debt Total | 288.7M | 396.4M | 665.1M | 504.8M | 580.5M | 408.1M | |
Other Current Assets | 41.9M | 58.7M | 57.6M | 49.2M | 56.5M | 40.0M | |
Total Liab | 709.6M | 1.2B | 1.1B | 1.1B | 1.3B | 938.5M | |
Net Invested Capital | 781.0M | 1.0B | 778.8M | 728.7M | 838.0M | 684.6M | |
Short Long Term Debt | 3M | 4.2M | 5.3M | 75M | 86.3M | 90.6M | |
Total Current Assets | 391.8M | 429.0M | 414.6M | 476.4M | 547.9M | 350.1M | |
Net Working Capital | 264.5M | 211.9M | 149.1M | 106.4M | 122.4M | 140.9M | |
Short Term Debt | 4.2M | 17.5M | 23.2M | 80.8M | 92.9M | 97.6M | |
Long Term Debt | 396.4M | 665.1M | 504.8M | 422.7M | 486.1M | 501.0M | |
Intangible Assets | 688.7M | 594.7M | 500.6M | 396.6M | 356.9M | 474.1M |
GoHealth Key Income Statement Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Tax Provision | 43K | (24K) | 764K | 67K | 77.1K | 73.2K | |
Interest Expense | 33.0M | 33.5M | 57.1M | 69.5M | 79.9M | 83.9M | |
Total Revenue | 877.4M | 1.1B | 631.7M | 734.7M | 844.9M | 746.5M | |
Gross Profit | 678.1M | 823.1M | 444.0M | 575.7M | 662.1M | 550.8M | |
Operating Income | (44.5M) | (102.2M) | (281.1M) | (81.7M) | (73.5M) | (77.2M) | |
Ebit | (887.8M) | (1.6B) | (1.1B) | (81.6M) | (73.5M) | (77.2M) | |
Ebitda | 34.4M | (393.2M) | (174.1M) | 24.1M | 21.7M | 22.8M | |
Cost Of Revenue | 199.2M | 239.3M | 187.7M | 159.0M | 182.8M | 195.7M | |
Income Before Tax | (97.2M) | (534.2M) | (375.6M) | (151.1M) | (136.0M) | (142.8M) | |
Net Income | (97.2M) | (534.2M) | (376.4M) | (63.3M) | (56.9M) | (59.8M) | |
Income Tax Expense | 43K | (24K) | 764K | 154K | 177.1K | 176.2K |
GoHealth Key Cash Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Change In Cash | 132.0M | (59.9M) | (67.9M) | 74.3M | 66.9M | 70.3M | |
Net Borrowings | 295.5M | (495.5M) | 265.7M | (163.0M) | (146.7M) | (139.3M) | |
Free Cash Flow | (128.7M) | (318.8M) | 47.4M | 95.4M | 109.7M | 115.2M | |
Depreciation | 98.6M | 107.5M | 107.0M | 105.7M | 121.6M | 84.0M | |
Other Non Cash Items | 20.4M | 8.3M | 33.0M | 19.0M | 17.1M | 16.2M | |
Capital Expenditures | 14.5M | 19.8M | 13.5M | 13.7M | 15.8M | 13.9M | |
Net Income | (97.2M) | (534.2M) | (376.4M) | (151.3M) | (136.1M) | (143.0M) | |
End Period Cash Flow | 144.2M | 84.4M | 16.5M | 90.8M | 104.4M | 63.9M | |
Change To Netincome | 158.8M | 181.3M | 431.9M | 27.9M | 32.0M | 30.4M |
GoHealth Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining GoHealth's current stock value. Our valuation model uses many indicators to compare GoHealth value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across GoHealth competition to find correlations between indicators driving GoHealth's intrinsic value. More Info.GoHealth is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, GoHealth's Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the GoHealth's earnings, one of the primary drivers of an investment's value.GoHealth Systematic Risk
GoHealth's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. GoHealth volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on GoHealth correlated with the market. If Beta is less than 0 GoHealth generally moves in the opposite direction as compared to the market. If GoHealth Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one GoHealth is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of GoHealth is generally in the same direction as the market. If Beta > 1 GoHealth moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in GoHealth Stock are looking for potential investment opportunities by analyzing not only static indicators but also various GoHealth's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of GoHealth growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
GoHealth February 16, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of GoHealth help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of GoHealth. We use our internally-developed statistical techniques to arrive at the intrinsic value of GoHealth based on widely used predictive technical indicators. In general, we focus on analyzing GoHealth Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build GoHealth's daily price indicators and compare them against related drivers.
Downside Deviation | 3.74 | |||
Information Ratio | 0.1572 | |||
Maximum Drawdown | 27.07 | |||
Value At Risk | (5.48) | |||
Potential Upside | 10.05 |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GoHealth. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in GoHealth Stock, please use our How to Invest in GoHealth guide.You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Property & Casualty Insurance space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GoHealth. If investors know GoHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GoHealth listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 4.241 | Earnings Share (3.29) | Revenue Per Share | Quarterly Revenue Growth (0.10) | Return On Assets |
The market value of GoHealth is measured differently than its book value, which is the value of GoHealth that is recorded on the company's balance sheet. Investors also form their own opinion of GoHealth's value that differs from its market value or its book value, called intrinsic value, which is GoHealth's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GoHealth's market value can be influenced by many factors that don't directly affect GoHealth's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GoHealth's value and its price as these two are different measures arrived at by different means. Investors typically determine if GoHealth is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GoHealth's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.